SPC139

HPV L1 veirulíkar agnir 16 + 18 + 52

  • Status:
    Veitt
  • Application date:
    8.12.2015
  • Application published:
    15.1.2016
  • Grant published:
    15.6.2017
  • Max expiry date:
    11.12.2030
  • Next due date:
    30.6.2026
  • Medicine name:
    Gardasil 9
  • Medicine for children:
    Yes

Timeline

Today
8.12.2015Application
15.1.2016Publication
15.6.2017Registration
13.6.2026Expires

Marketing license

  • IS authorization number:
    EU/1/15/1007/002-003 & EU/1/15/1007/001
  • Date:
    8.7.2015
  • Foreign authorization number:
    EU/1/15/1007/001-003
  • Date:
    10.6.2015

Owner

  • Name:
    GlaxoSmithKline Biologicals SA
  • Address:
    Rue de l'Institut 89, Rixensart BE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 2.4.2025

Expires: 13.6.2026

Payer: Árnason Faktor ehf.

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 27.03.2023

Upload documents